AU5461286A - N-substituted amides or aromatic sulfonic acids and their use ina treating thromboembolic disorders - Google Patents

N-substituted amides or aromatic sulfonic acids and their use ina treating thromboembolic disorders

Info

Publication number
AU5461286A
AU5461286A AU54612/86A AU5461286A AU5461286A AU 5461286 A AU5461286 A AU 5461286A AU 54612/86 A AU54612/86 A AU 54612/86A AU 5461286 A AU5461286 A AU 5461286A AU 5461286 A AU5461286 A AU 5461286A
Authority
AU
Australia
Prior art keywords
sulfonic acids
aromatic sulfonic
thromboembolic disorders
substituted amides
treating thromboembolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54612/86A
Inventor
Helmut Ballhause
Walter Haarmann
Armin Heckel
Erich Muller
Berthold Narr
Josef Nickl
Johannes Weisenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853508692 external-priority patent/DE3508692A1/en
Priority claimed from DE19853541854 external-priority patent/DE3541854A1/en
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU5461286A publication Critical patent/AU5461286A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU54612/86A 1985-03-12 1986-03-11 N-substituted amides or aromatic sulfonic acids and their use ina treating thromboembolic disorders Abandoned AU5461286A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19853508692 DE3508692A1 (en) 1985-03-12 1985-03-12 3-[4-(2-Benzenesulfonylaminoethyl)benzoyl]propionic acid, medicaments containing this compound and processes for their preparation
DE3508692 1985-03-12
DE3541854 1985-11-27
DE19853541854 DE3541854A1 (en) 1985-11-27 1985-11-27 Novel sulphonylaminoethyl compounds, medicaments containing these compounds and processes for their preparation

Publications (1)

Publication Number Publication Date
AU5461286A true AU5461286A (en) 1986-10-16

Family

ID=25830225

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54612/86A Abandoned AU5461286A (en) 1985-03-12 1986-03-11 N-substituted amides or aromatic sulfonic acids and their use ina treating thromboembolic disorders

Country Status (11)

Country Link
EP (1) EP0194548A3 (en)
AU (1) AU5461286A (en)
DK (1) DK110886A (en)
ES (5) ES8800664A1 (en)
FI (1) FI860971A (en)
GR (1) GR860654B (en)
HU (1) HU195770B (en)
IL (1) IL78079A0 (en)
NO (1) NO860918L (en)
PH (1) PH22480A (en)
PT (1) PT82169B (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597000B2 (en) * 1985-10-02 1990-05-24 Boehringer Mannheim Gmbh Sulphonylphenylalkylamines, processes for the preparation thereof and pharmaceutical compositions containing them
AU597707B2 (en) * 1986-08-06 1990-06-07 Tanabe Seiyaku Co., Ltd. Sulphonamide containing phenoxyacetic acid derivatives and their preparation
AU602171B2 (en) * 1986-10-27 1990-10-04 Chemische Fabrik Stockhausen Gmbh A process for the production of N,N-disubstituted beta-aminopropionic acids and use of these as emulsifying agents, wetting agents and surfactants in cleaning agents and for waterproofing leather and skins
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5543409A (en) * 1993-12-28 1996-08-06 Tanabe Seiyaku Co., Ltd. Indane derivatives for treating endotoxin shock and/or nephritis
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US5958905A (en) * 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6248767B1 (en) 1997-04-28 2001-06-19 Texas Biotechnology Corp. Formulation of sulfonamides for treatment of endothelin-mediated disorders
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623944A1 (en) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K NEW BENZOLSULFONAMIDO INDANYL COMPOUNDS, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
US4752613A (en) * 1987-08-03 1988-06-21 E. R. Squibb & Sons, Inc. Sulphonamidothienylcarboxylic acid compounds
AT393962B (en) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistic pharmaceutical combination with a content of a phosphodiesterase inhibitor and the use thereof
DE3819052A1 (en) * 1988-06-04 1989-12-07 Basf Ag NEW SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US4975452A (en) * 1989-06-02 1990-12-04 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
US5106991A (en) * 1989-06-02 1992-04-21 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
DE4035961A1 (en) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
US5280034A (en) * 1991-08-23 1994-01-18 E. R. Squibb & Sons, Inc. Bis-heterocyclic prostaglandin analogs
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
DE4213919A1 (en) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US5739132A (en) * 1992-07-02 1998-04-14 Tanabe Seiyaku Co., Ltd. Pyridazinone derivatives and processes for preparing the same
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US5965732A (en) * 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co Pyridazinone derivatives and processes for their preparation
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (en) * 1995-10-11 1997-05-13 Bristol Myers Squibb Co Substituted biphenylsulfonamide endothelin antagonist
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
AU717230B2 (en) 1996-02-20 2000-03-23 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
CA2367916A1 (en) 1999-03-19 2000-09-28 Ambarish Singh Methods for the preparation of biphenyl isoxazole sulfonamides
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
JP5335675B2 (en) 2006-07-25 2013-11-06 セファロン、インク． Pyrididinone derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000377A1 (en) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim NEW SULPHONAMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3535167A1 (en) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh NEW SULFONYL-PHENYL (ALKYL) AMINES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597000B2 (en) * 1985-10-02 1990-05-24 Boehringer Mannheim Gmbh Sulphonylphenylalkylamines, processes for the preparation thereof and pharmaceutical compositions containing them
AU597707B2 (en) * 1986-08-06 1990-06-07 Tanabe Seiyaku Co., Ltd. Sulphonamide containing phenoxyacetic acid derivatives and their preparation
AU602171B2 (en) * 1986-10-27 1990-10-04 Chemische Fabrik Stockhausen Gmbh A process for the production of N,N-disubstituted beta-aminopropionic acids and use of these as emulsifying agents, wetting agents and surfactants in cleaning agents and for waterproofing leather and skins
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6331637B1 (en) 1993-10-21 2001-12-18 Texas Biotechnology Corporation N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5605901A (en) * 1993-12-28 1997-02-25 Tanabe Seiyaku Co., Ltd. Indane derivatives, processes for preparing the same and synthetic intermediate of the same
US5543409A (en) * 1993-12-28 1996-08-06 Tanabe Seiyaku Co., Ltd. Indane derivatives for treating endotoxin shock and/or nephritis
US6384261B1 (en) 1996-03-26 2002-05-07 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5958905A (en) * 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US6632829B2 (en) 1996-04-04 2003-10-14 Texas Biotechnology Corp. Sulfonamides and derivatives thereof that modulate the activity of endothelin
US6329387B2 (en) 1996-04-15 2001-12-11 Texas Biotechnology Corporation. Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6013655A (en) * 1996-04-15 2000-01-11 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6545014B2 (en) 1996-04-15 2003-04-08 Texas Biotechnology Corporation Method of treating glaucoma
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6420567B1 (en) 1996-09-27 2002-07-16 Texas Biotechnology Corporation N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelin
US6248767B1 (en) 1997-04-28 2001-06-19 Texas Biotechnology Corp. Formulation of sulfonamides for treatment of endothelin-mediated disorders
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US6458805B2 (en) 1997-04-28 2002-10-01 Texas Biotechnology Corporation Formulation of sulfonamides for treatment of endothelin-mediated disorders
US6683103B2 (en) 1997-04-28 2004-01-27 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders

Also Published As

Publication number Publication date
EP0194548A3 (en) 1988-08-17
EP0194548A2 (en) 1986-09-17
GR860654B (en) 1986-07-11
PH22480A (en) 1988-09-12
ES8705378A1 (en) 1987-05-01
ES557211A0 (en) 1987-05-16
DK110886A (en) 1986-09-13
ES8705856A1 (en) 1987-05-16
FI860971A (en) 1986-09-13
HUT42062A (en) 1987-06-29
NO860918L (en) 1986-09-15
ES557212A0 (en) 1987-05-16
ES8705855A1 (en) 1987-05-16
ES8800664A1 (en) 1987-11-16
ES552870A0 (en) 1987-11-16
PT82169B (en) 1988-01-04
PT82169A (en) 1986-04-01
DK110886D0 (en) 1986-03-11
FI860971A0 (en) 1986-03-10
ES557213A0 (en) 1987-05-16
HU195770B (en) 1988-07-28
IL78079A0 (en) 1986-07-31
ES557210A0 (en) 1987-05-01
ES8705857A1 (en) 1987-05-16

Similar Documents

Publication Publication Date Title
AU5461286A (en) N-substituted amides or aromatic sulfonic acids and their use ina treating thromboembolic disorders
AU590759B2 (en) Fluid treatment process and apparatus
AU587618B2 (en) Ozone injection method and apparatus
PH23770A (en) Trifluoro-quinoline-3-carboxylic acids and their use as antibacterial agents
EP0193374A3 (en) Thermoplastic aromatic polyamideimide copolymers and process for their preparation
AU578380B2 (en) Spray drying apparatus and method
AU590640B2 (en) Dementia-improving and therapeutic agents
AU584668B2 (en) Novel heterocyclic amides useful as anti-inflammatory and anti-allergy agents
AU4103185A (en) Benzamide and anilide derivatives
PH25019A (en) New benzamides and their use in treating gastrointestinal disorders
AU564013B2 (en) 1,8-bridged 4-quinolone-3-carboxylic acids and derivatives
AU568190B2 (en) Blends of olefinic and monovinylidene aromatic polymers
AU5787786A (en) N-(3-chloro-4-isopropylphenyl)carboxamide derivative and selective herbicide
AU578737B2 (en) N-(Aminoalkyl)-2-Phenyl-2-Hydroxy-Ethylamine Derivatives
EP0228625A3 (en) Peptide derivatives inhibitors of hydroxyling enzymes, their process of preparation, the agents thereof and their use
AU5420986A (en) 2,3,4-triacylhexoses and mixtures thereof
AU581075B2 (en) Liquid distributor and use thereof
ZA8610B (en) 1,3,4-trisubstituted azacycloalkanes and azacycloalkenes
AU589665B2 (en) Substituted dipeptide amides
PH23435A (en) Benzamide and application thereof in the therapeutic field
AU591106B2 (en) Improvements in or relating to substituted N-(phenoxyethyl) nicotinamides
AU6079486A (en) Photoreactive iminopyridinium-ylides and iminopyrazinium- ylides
AU5178486A (en) 1,3,4-trisubstituted azacyloalkanes and azacycloalkenes
AU573033B2 (en) N-substituted salicylamides and their use as fungicides
AU561862B2 (en) Treating high protein oedemas with 7 hydroxy-coumarin